Swedish drugmaker MIP Technologies AB says that it has launched MIP4SPE beta blocker, a class-selective solid-phase extraction sorbent, for the analytical separations market. The product is designed to identify beta blocker contamination of the environment, which has become more pf a problem due to their increased use.
The firm added that MIP4SPE had been used to test natural water by Spain's Department of Environmental Chemistry (IIQAB-CSIC), which reported that it offers good efficiency and selectivity.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze